Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2003-11-26
pubmed:abstractText
To characterize the value of total lymphocyte counts in predicting risk of death among patients initiating triple combination antiretroviral therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1359-6535
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
379-84
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:14640384-Adolescent, pubmed-meshheading:14640384-Adult, pubmed-meshheading:14640384-Anti-HIV Agents, pubmed-meshheading:14640384-Antiretroviral Therapy, Highly Active, pubmed-meshheading:14640384-CD4 Lymphocyte Count, pubmed-meshheading:14640384-Cohort Studies, pubmed-meshheading:14640384-Disease Progression, pubmed-meshheading:14640384-Drug Therapy, Combination, pubmed-meshheading:14640384-Female, pubmed-meshheading:14640384-HIV Infections, pubmed-meshheading:14640384-HIV Protease Inhibitors, pubmed-meshheading:14640384-HIV-1, pubmed-meshheading:14640384-Humans, pubmed-meshheading:14640384-Lymphocyte Count, pubmed-meshheading:14640384-Male, pubmed-meshheading:14640384-Middle Aged, pubmed-meshheading:14640384-Poverty, pubmed-meshheading:14640384-Predictive Value of Tests, pubmed-meshheading:14640384-Proportional Hazards Models, pubmed-meshheading:14640384-Reverse Transcriptase Inhibitors, pubmed-meshheading:14640384-Survival Analysis, pubmed-meshheading:14640384-Viral Load
pubmed:year
2003
pubmed:articleTitle
Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
pubmed:affiliation
Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver, British Columbia, Canada.
pubmed:publicationType
Journal Article